TORL BioTherapeutics LLC

Overview

Funding and backers

Total raised
$158.3M
1 round on record
Latest round
$158.3M
Venture round · Apr 2024 · 2 yr ago
Backers
2
Xontogeny, RA Capital Management
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 4, 2024 Raised a round Venture round $158.3M · SEC Form D
Tractionpublic signals, read monthly
Web presence
top 9%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Apr 2024 $158.3M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity TORL Biotherapeutics LLC SEC Form D
Founders and leadersfrom filings, registers and the company's site
Mark AllesExecutive Officer, DirectorSEC Form D
David LicataExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Financials

Total raised
$158.3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $158.3M Details

People

Mark Alles
Executive Officer, Director
David Licata
Executive Officer, Director
Mark Attanasio
Director
Neil O'Brien
Director
Amit Sinha
Director
Lynn Seely
Director
Dennis Slamon
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
XontogenyVia a fund
27 portfolio companies: Zucara, Tellus Therapeutics, VivoSense and 24 more
222 portfolio companies: Verdiva Bio, PLEASE READ THIS AG, Vivace Therapeutics and 219 more

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Culver City United States
HQ